Accelerate Pheno™ blood culture detection system: a literature review

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Singer M, Deutschman CS, Seymour CW et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8), 801–810 (2016).
  Medline CASGoogle Scholar
• 2. Suarez De La Rica A, Gilsanz F, Maseda E. Epidemiologic trends of sepsis in western countries. Ann. Transl. Med. 4(17), 325 (2016).
  MedlineGoogle Scholar
• 3. O'Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance. (2014). https://amr-review.org/sites/default/files/AMR Review Paper - Tackling a crisis for the health and wealth of nations_1.pdf
  Google Scholar
• 4. Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34, 1589–1596 (2006).
  MedlineGoogle Scholar
• 5. Gaynes R, Edwards JR. National nosocomial infections surveillance system. Overview of nosocomial infections caused by Gram-negative bacilli. Clin. Infect. Dis. 41(6), 848–854 (2005).
  MedlineGoogle Scholar
• 6. Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clin. Proc. 86(2), 156–167 (2011).
  MedlineGoogle Scholar
• 7. van Belkum A, Dunne WM Jr. Next-generation antimicrobial susceptibility testing. J. Clin. Microbiol. 51, 2018–2024 (2013).
  MedlineGoogle Scholar
• 8. Trotter AJ, Aydin A, Strinden MJ, O'Grady J. Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance. Curr. Opin. Microbiol. 51, 39–45 (2019).
  Medline CASGoogle Scholar
• 9. Peker N, Couto N, Sinha B, Rossen JW. Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches. Clin. Microbiol. Infect. 24(9), 944–955 (2018).
  Medline CASGoogle Scholar
• 10. Liesenfeld O, Lehman L, Hunfeld KP, Kost G. Molecular diagnosis of sepsis: new aspects and recent developments. Eur. J. Microbiol. Immunol. 4(1), 1–25 (2014).
  Medline CASGoogle Scholar
• 11. Idelevich EA, Schüle I, Grünastel B, Wüllenweber J, Peters G, Becker K. Rapid identification of microorganisms from positive blood cultures by MALDI TOF mass spectrometry subsequent to very short-term incubation on solid medium. Clin. Microbiol. Infect. 20(10), 1001–1006 (2014).
  Medline CASGoogle Scholar
• 12. Mauri C, Principe L, Bracco S et al. Identification by mass spectrometry and automated susceptibility testing from positive bottles: a simple, rapid, and standardized approach to reduce the turnaround time in the management of blood cultures. BMC Infect. Dis. 17(1), 749 (2017).
  MedlineGoogle Scholar
• 13. Chandrasekaran S, Abbott A, Campeau S et al. Direct-from-blood-culture disk diffusion to determine antimicrobial susceptibility of Gram-negative bacteria: preliminary report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group. J. Clin. Microbiol. 56, e01678–17 (2018).
  Medline CASGoogle Scholar
• 14. De Socio G, Di Donato F, Paggi R et al. Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection. Eur. J. Clin. Microbiol. Infect. Dis. 37, 2313–2322 (2018).
  MedlineGoogle Scholar
• 15. Huerta LE, Rice TW. Pathologic difference between sepsis and bloodstream infections. Appl. Lab. Med. 3, 654–663 (2019).
  Medline CASGoogle Scholar
• 16. Marschal M, Bachmaier J, Autenrieth I, Oberhettinger P, Willmann M, Peter S. Evaluation of the Accelerate Pheno system for fast identification and antimicrobial susceptibility testing from positive blood cultures in bloodstream infections caused by Gram-negative pathogens. J. Clin. Microbiol. 55(7), 2116–2126 (2017). • First study which describes diagnostic accuracy of Accelerate Pheno™ (ACC).
  Medline CASGoogle Scholar
• 17. Ehren K, Meißner A, Jazmati N et al. Clinical impact of rapid species identification from positive blood cultures with same-day phenotypic antimicrobial susceptibility testing on the management and outcome of bloodstream infections”. Clin. Infect. Dis. 20(20), 1–9 (2019).
  Google Scholar
• 18. Ullberg M, Özenci V. Identification and antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria from positive blood cultures using the Accelerate Pheno™ system. Eur. J. Clin. Microbiol. Infect. Dis. 39, 139–149 (2020).
  MedlineGoogle Scholar
• 19. Descours G, Desmurs L, Hoang TLT et al. Evaluation of the Accelerate PhenoTM system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections. Eur. J. Clin. Microbiol. Infect. Dis. 37, 1573–1583 (2018).
  Medline CASGoogle Scholar
• 20. Giordano C, Piccoli E, Brucculeri V, Barnini S. A prospective evaluation of two rapid phenotypical antimicrobial susceptibility technologies for the diagnostic stewardship of sepsis. Biomed. Res. Int. 2018, 6976923 (2018).
  MedlineGoogle Scholar
• 21. De Socio G, Belati A, Paggi R et al. Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience. New Microbiol. 43(1), 6–12 (2020). • Positive impact of ACC on time to report in a laboratory using lab-automation to speed up positive blood culture results.
  MedlineGoogle Scholar
• 22. Pancholi P, Carroll KC, Buchan BW et al. Multicenter evaluation of the Accelerate PhenoTest BC kit for rapid identification and phenotypic antimicrobial susceptibility testing using morphokinetic cellular analysis. J. Clin. Microbiol. 56(4), e01329–17 (2018). •• Multi-facility study using broth microdilution method to evaluate diagnostic accuracy of ACC for US FDA acceptability.
  Medline CASGoogle Scholar
• 23. Charnot-Katsikas A, Tesic V, Love N et al. Use of the Accelerate Pheno system and identification and antimicrobial susceptibility testing of pathogens in positive blood cultures and impact on time to results and workflow. J. Clin. Microbiol. 56(1), e01166–17 (2018).
  Medline CASGoogle Scholar
• 24. Burnham J, Wallace M, Fuller B et al. Clinical effect of expedited pathogen identification and susceptibility testing for Gram-negative bacteremia and candidemia by use of the Accelerate Pheno™ System. JALM 3(4), 569–579 (2019).
  CASGoogle Scholar
• 25. Pantel A, Monier J, Lavigne JP. Performance of the Accelerate Pheno™ system for identification and antimicrobial susceptibility testing of a panel of multi-drug resistant Gram-negative bacilli directly from positive blood cultures. J. Antimicrob. Chemother. 73(6), 1546–1552 (2018).
  Medline CASGoogle Scholar
• 26. Calderaro A, Buttrini M, Martinelli M et al. Rapid microbial identification and phenotypic antimicrobial susceptibility testing directly from positive blood cultures: a new platform compared to routine laboratory methods. Diagn. Microbiol. Infect. Dis. 96(3), 114955 (2019).
  MedlineGoogle Scholar
• 27. Lutgring J, Bittencourt C, McElvania TeKippe E, Cavuoti D, Hollaway R, Burdb E. Evaluation of the Accelerate Pheno system: results from two academic medical centers. J. Clin. Microbiol. 56(4), e01672–17 (2018).
  Medline CASGoogle Scholar
• 28. Humphries RM, Ambler J, Mitchell SL et al. CLSI Methods Development and Standardization Working Group best practices for evaluation of antimicrobial susceptibility tests. J. Clin. Microbiol. 56, e01934–17 (2018).
  Medline CASGoogle Scholar
• 29. Banerjee R, Komarow L, Virk A et al. Randomized trial evaluating clinical impact of RAPid IDentification and susceptibility testing for gram negative bacteremia (RAPIDS-GN). Clin. Infect. Dis. (2020). https://doi.org/10.1093/cid/ciaa528 •• Randomized, controlled study which demonstrates that the implementation of ACC in antimicrobial stewardship program improves patient management and therapy.
  Google Scholar
• 30. Elliott G, Malczynski M, Barr VO et al. Evaluation of the impact of the Accelerate Pheno™ system on time to result for differing antimicrobial stewardship intervention models in patients with gram negative bloodstream infections. BMC Infec. Dis. 19(1), 942 (2019).
  MedlineGoogle Scholar
• 31. Oppermann N, Ndobegang A, Sikorski A et al. Evaluation of antimicrobial susceptibility testing assays for ceftazidime-avibactam and ceftolozane-tazobactam with Gram-negative bacteria directly from positive blood culture on the Accelerate Pheno system. ECCMID 2020 Abstract 5834 (2020).
  Google Scholar
• 32. Buehler SS, Madison B, Snyder SR et al. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with blood-stream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin. Microbiol. Rev. 29, 59–103 (2016).
  MedlineGoogle Scholar
• 33. Henig O, Kaye KS, Chandramohan S et al. The hypothetical impact of Accelerate Pheno on time to effective therapy and time to definitive therapy for bloodstream infections due to drug-resistant gram negative bacilli. Antimicrob. Agent and Chemother. 63(3), e01477–18 (2019).
  Medline CASGoogle Scholar
• 34. Henig O, Cooper CC, Kaye KS et al. The hypothetical impact of Accelerate PhenoTM system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification. J. Antimicrob. Chemother. 74(1), i32–i39 (2019). • Evaluates the role of ACC in antibiotic sparing.
  Medline CASGoogle Scholar
• 35. Dare RK, Lusardi K, Pearson C et al. Clinical impact of accelerate PhenoTM rapid blood culture detection system in bacteremic patients. Clin. Infect. Dis. (2020). https://doi.org/10.1093/cid/ciaa649 •• Quasi-experimental study which shows a 2-day reduction of length of stay in patients with ACC testing.
  MedlineGoogle Scholar
• 36. Micek ST, Arnold H, Juang P et al. Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot study. Clin. Ther. 36(9), 1226–1232 (2014).
  MedlineGoogle Scholar
• 37. Uehara Y, Yagoshi M, Tanimichi Y et al. Impact of reporting gram stain results from blood culture bottles on the selection of antimicrobial agents. Am. J. Clin. 132(1), 18–25 (2009).
  Google Scholar
• 38. Clancy CJ, Pappas PG, Vazquez J et al. Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): a prospective, multicenter study of the T2Candida Panel. Clin. Infect. Dis. 66, 1678–1686 (2018).
  Medline CASGoogle Scholar
• 39. Seng P, Drancourt M, Gouriet F et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Infect. Dis. 49(4), 543–551 (2009).
  Medline CASGoogle Scholar
• 40. Arena F, Giani T, Pollini S, Viaggi B, Pecile P, Rossolini GM. Molecular antibiogram in diagnostic clinical microbiology: advantages and challenges. Future Microbiol. 12, 361–364 (2017). •• New diagnostic technologies from a clinical point of view.
  CASGoogle Scholar
• 41. Ramanan P, Bryson AL, Binnicker MJ, Pritt BS, Patel R. Syndromic panel-based testing in clinical microbiology. Clin. Microbiol. Rev. 31(1), e00024–17 (2017).
  MedlineGoogle Scholar
• 42. Messacar K, Parker SK, Todd JK, Dominguez SR. Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J. Clin. Microbiol. 55(3), 715–723 (2017).
  MedlineGoogle Scholar
• 43. Mangioni D, Viaggi B, Giani T et al. Diagnostic stewardship for sepsis: the need for risk stratification to triage patients for fast microbiology workflows. Future Microbiol. 14, 169–174 (2019).
  CASGoogle Scholar